8-71215529-C-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000503.6(EYA1):​c.1476-21G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.323 in 1,610,736 control chromosomes in the GnomAD database, including 91,815 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.32 ( 8629 hom., cov: 33)
Exomes 𝑓: 0.32 ( 83186 hom. )

Consequence

EYA1
NM_000503.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.593

Publications

11 publications found
Variant links:
Genes affected
EYA1 (HGNC:3519): (EYA transcriptional coactivator and phosphatase 1) This gene encodes a member of the eyes absent (EYA) family of proteins. The encoded protein may play a role in the developing kidney, branchial arches, eye, and ear. Mutations of this gene have been associated with branchiootorenal dysplasia syndrome, branchiootic syndrome, and sporadic cases of congenital cataracts and ocular anterior segment anomalies. A similar protein in mice can act as a transcriptional activator. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Dec 2013]
EYA1 Gene-Disease associations (from GenCC):
  • branchio-oto-renal syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • branchiootorenal syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • branchiootic syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • branchiootic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 8-71215529-C-A is Benign according to our data. Variant chr8-71215529-C-A is described in ClinVar as Benign. ClinVar VariationId is 1253275.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.739 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EYA1NM_000503.6 linkc.1476-21G>T intron_variant Intron 15 of 17 ENST00000340726.8 NP_000494.2 Q99502-1A0A024R813B3KXR1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EYA1ENST00000340726.8 linkc.1476-21G>T intron_variant Intron 15 of 17 1 NM_000503.6 ENSP00000342626.3 Q99502-1

Frequencies

GnomAD3 genomes
AF:
0.320
AC:
48658
AN:
151902
Hom.:
8613
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.246
Gnomad AMI
AF:
0.402
Gnomad AMR
AF:
0.413
Gnomad ASJ
AF:
0.339
Gnomad EAS
AF:
0.758
Gnomad SAS
AF:
0.468
Gnomad FIN
AF:
0.369
Gnomad MID
AF:
0.310
Gnomad NFE
AF:
0.291
Gnomad OTH
AF:
0.325
GnomAD2 exomes
AF:
0.378
AC:
94834
AN:
250698
AF XY:
0.374
show subpopulations
Gnomad AFR exome
AF:
0.240
Gnomad AMR exome
AF:
0.511
Gnomad ASJ exome
AF:
0.346
Gnomad EAS exome
AF:
0.761
Gnomad FIN exome
AF:
0.346
Gnomad NFE exome
AF:
0.289
Gnomad OTH exome
AF:
0.338
GnomAD4 exome
AF:
0.323
AC:
471592
AN:
1458716
Hom.:
83186
Cov.:
33
AF XY:
0.325
AC XY:
236222
AN XY:
725890
show subpopulations
African (AFR)
AF:
0.238
AC:
7939
AN:
33422
American (AMR)
AF:
0.499
AC:
22301
AN:
44684
Ashkenazi Jewish (ASJ)
AF:
0.349
AC:
9104
AN:
26104
East Asian (EAS)
AF:
0.758
AC:
30057
AN:
39676
South Asian (SAS)
AF:
0.435
AC:
37498
AN:
86198
European-Finnish (FIN)
AF:
0.337
AC:
18021
AN:
53396
Middle Eastern (MID)
AF:
0.279
AC:
1605
AN:
5762
European-Non Finnish (NFE)
AF:
0.293
AC:
324687
AN:
1109238
Other (OTH)
AF:
0.338
AC:
20380
AN:
60236
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
15057
30114
45170
60227
75284
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11108
22216
33324
44432
55540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.320
AC:
48712
AN:
152020
Hom.:
8629
Cov.:
33
AF XY:
0.329
AC XY:
24434
AN XY:
74318
show subpopulations
African (AFR)
AF:
0.246
AC:
10188
AN:
41456
American (AMR)
AF:
0.414
AC:
6318
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.339
AC:
1178
AN:
3470
East Asian (EAS)
AF:
0.759
AC:
3921
AN:
5168
South Asian (SAS)
AF:
0.469
AC:
2250
AN:
4800
European-Finnish (FIN)
AF:
0.369
AC:
3897
AN:
10568
Middle Eastern (MID)
AF:
0.316
AC:
93
AN:
294
European-Non Finnish (NFE)
AF:
0.291
AC:
19800
AN:
67980
Other (OTH)
AF:
0.333
AC:
702
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1607
3214
4821
6428
8035
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
480
960
1440
1920
2400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.275
Hom.:
3482
Bravo
AF:
0.322
Asia WGS
AF:
0.615
AC:
2142
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Branchiootic syndrome 1 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Branchiootorenal syndrome 1 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Otofaciocervical syndrome 1 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
8.3
DANN
Benign
0.67
PhyloP100
0.59
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3735935; hg19: chr8-72127764; COSMIC: COSV58164182; COSMIC: COSV58164182; API